CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.leukres.2018.08.007
PubMed Identifier: 30119908
Publication URI: http://europepmc.org/abstract/MED/30119908
Type: Journal Article/Review
Volume: 74
Parent Publication: Leukemia research
ISSN: 0145-2126